SIMCOR® (niacin extended-release/simvastatin tablets)

Guidelines & HDL-C

National Guidelines

National guidelines support comprehensive lipid management


Patients may present with different combinations of lipid abnormalities

NCEP recommends initiating lifestyle changes such as diet and exercise, which continue during drug treatment1
Cholestrol Guidelines support comprehensive lipid management
NCEP recommends an optional LDL-C goal of <70 mg/dL for very high-risk patients such as patients with established cardiovascular disease (CVD) plus multiple risk factors (especially diabetes)2
According to the AHA, HDL-C <40 mg/dL is low for men; HDL-C <50 mg/dL is low for women3
HDL-C ≥60 mg/dL counts as a "negative" risk factor; its presence removes 1 risk factor from that total count of risk factors2
NCEP does not specify a goal for HDL-C raising or triglyceride lowering

Lipid Therapy

a CHD risk equivalent: patients with multiple risk factors and 10-year risk for CHD >20%, those diagnosed with diabetes or a form of clinical atherosclerotic disease including peripheral arterial disease, abdominal aortic aneurysm, or carotid artery disease.
b Major risk factors (exclusive of LDL cholesterol) that modify LDL goals include: cigarette smoking, hypertension (BP ≥140/90 mmHg or on antihypertensive medication), low HDL-C (<40 mg/dL), family history of premature coronary heart disease (CHD male first-degree relative <55 years of age and in female first-degree relative <65 years of age), and age (men ≥45 years; women ≥55 years).

References

  1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106(25):3143-421.
  2. Grundy SM, Cleeman JI, Merz NB, et al; for the Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Guidelines. Circulation. 2004;110:227-239.
  3. American Heart Association. Cholesterol levels: AHA recommendation. Available at: http://www.americanheart.org/presenter.jhtml?identifier=4500. Accessed July 28, 2010.
  4. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung and Blood Institute. J Am Coll Cardiol. 2006;47:2130-2139.
  5. Brunzell JD, Davidson M, Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2008;51:1512-1524.